A Randomized, Placebo-Controlled, Double-Blind Trial of Duloxetine in the Treatment of Patients With Chronic Fatigue Syndrome

Trial Profile

A Randomized, Placebo-Controlled, Double-Blind Trial of Duloxetine in the Treatment of Patients With Chronic Fatigue Syndrome

Completed
Phase of Trial: Phase II/III

Latest Information Update: 26 Aug 2015

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Chronic fatigue syndrome
  • Focus Therapeutic Use
  • Acronyms CFS
  • Most Recent Events

    • 24 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 01 Apr 2014 New trial record
    • 02 Jul 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top